Rolf Kreienberg

Q: What Schools Are Affiliated With Rolf Kreienberg

Rolf Kreienberg is affiliated with the following schools: University of Ulm, University of Mainz, University of Cologne, University of Bremen

Rolf Kreienberg's AcademicInfluence.com Rankings

Rolf Kreienberg

Philosophy

#10167

World Rank

#13913

Historical Rank

Logic

#7093

World Rank

#8732

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Rolf Kreienberg Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Rolf Kreienberg was a German gynaecologist and obstetrician. Life From 1966 to 1971, Kreienberg studied medicine at the universities of Mainz, Germany and Vienna, Austria. After his preliminary examination he temporarily stayed at the University of Vienna, Austria. In 1971, he passed the state medical examination in Mainz and completed his doctoral thesis in 1972, earning his license to practice medicine in 1973.

(See a Problem?)

Rolf Kreienberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pathologic complete response after neoadjuvant chemotherapy plus trastuzumab predicts favorable survival in human epidermal growth factor receptor 2-overexpressing breast cancer: results from the TECHNO trial of the AGO and GBG study groups. (2011) (472)
Neoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancer. (2012) (457)
Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial. (2012) (422)
Cognitive function during neoadjuvant chemotherapy for breast cancer (2007) (351)
Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. (1999) (275)
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer. (2001) (275)
Interleukin 21-induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. (2013) (250)
Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures (2001) (243)
Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy (2002) (234)
Long-Term Morbidity Following Axillary Dissection in Breast Cancer Patients – Clinical Assessment, Significance for Life Quality and the Impact of Demographic, Oncologic and Therapeutic Factors (2000) (219)
Induced micronucleus frequencies in peripheral lymphocytes as a screening test for carriers of a BRCA1 mutation in breast cancer families. (2000) (212)
Preoperative diagnosis of ovarian tumors with MR imaging: comparison with transvaginal sonography, positron emission tomography, and histologic findings. (2001) (206)
Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings. (2002) (199)
Intense dose-dense sequential chemotherapy with epirubicin, paclitaxel, and cyclophosphamide compared with conventionally scheduled chemotherapy in high-risk primary breast cancer: mature results of an AGO phase III study. (2010) (186)
A phase I/II trial of rAd/p53 (SCH 58500) gene replacement in recurrent ovarian cancer (2002) (171)
p53 mutations and expression in ovarian cancers: correlation with overall survival. (1999) (170)
Human ovarian tissue vitrification versus conventional freezing: morphological, endocrinological, and molecular biological evaluation. (2009) (141)
Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro (2005) (140)
Polymorphism C3435T of the MDR-1 gene predicts response to preoperative chemotherapy in locally advanced breast cancer. (2003) (139)
Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. (2000) (138)
Acrosomal status and mitochondrial activity of human spermatozoa vitrified with sucrose. (2008) (138)
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancer. (2009) (136)
Vaccination of Patients with Advanced Ovarian Carcinoma with the Anti-Idiotype ACA125 (2004) (136)
Phase III trial of sunitinib in combination with capecitabine versus capecitabine monotherapy for the treatment of patients with pretreated metastatic breast cancer. (2013) (133)
MRI of breast cancer: influence of chemotherapy on sensitivity. (1997) (128)
Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. (2002) (126)
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapy in 678 triple-negative primary breast cancers; results from the geparquinto study (GBG 44). (2013) (120)
Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Can (2001) (116)
Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients. (2010) (116)
Uterine arteriovenous malformations induced after diagnostic curettage: a systematic review (2011) (111)
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group. (1989) (110)
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects. (2006) (110)
Adipocyte fatty acid-binding protein as a novel prognostic factor in obese breast cancer patients (2009) (107)
Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. (2009) (105)
Links between DNA double strand break repair and breast cancer: accumulating evidence from both familial and nonfamilial cases. (2007) (103)
The Patient's Anastrozole Compliance to Therapy (PACT) Program: a randomized, in-practice study on the impact of a standardized information program on persistence and compliance to adjuvant endocrine therapy in postmenopausal women with early breast cancer. (2013) (102)
Standard treatment of female patients with breast cancer decreases substantially for women aged 70 years and older: a German clinical cohort study. (2010) (100)
Angiogenesis during primate placentation in health and disease. (2003) (99)
Mastectomy trends for early-stage breast cancer: a report from the EUSOMA multi-institutional European database. (2012) (95)
Intron 3 16 bp duplication polymorphism of p53 is associated with an increased risk for breast cancer by the age of 50 years. (2002) (90)
Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study (1994) (89)
Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines (1992) (89)
p53 germline polymorphisms are associated with an increased risk for breast cancer in German women. (1998) (89)
Role of SIRT1 in homologous recombination. (2010) (85)
Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. (2004) (83)
German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer. (2013) (83)
Accelerated partial breast irradiation (2007) (82)
Ultrasound-guided large-core needle biopsies of breast lesions: analysis of 962 cases to determine the number of samples for reliable tumour classification (2004) (82)
Potential role of Renin-Angiotensin-system for tumor angiogenesis in receptor negative breast cancer. (2008) (81)
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer (2018) (80)
High-dose chemotherapy with autologous hematopoietic stem-cell support compared with standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: first results of a randomized trial. (2004) (80)
Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial. (2009) (72)
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations (1999) (71)
Chlamydia trachomatis infection as a risk factor for infertility among women in Ghana, West Africa. (2008) (71)
Expression Profiling of Mammary Carcinoma Cell Lines: Correlation of in vitro Invasiveness with Expression of CD24 (2002) (71)
First-line trastuzumab plus epirubicin and cyclophosphamide therapy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: cardiac safety and efficacy data from the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) trial. (2010) (70)
Long term follow-up of patients with recurrent ovarian cancer after Ad p53 gene replacement with SCH 58500 (2002) (68)
Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion. (2003) (66)
VEGF induces ascites in ovarian cancer patients via increasing peritoneal permeability by downregulation of Claudin 5. (2012) (65)
Re-vascularisation in human ovarian tissue after conventional freezing or vitrification and xenotransplantation. (2010) (64)
Molecular biology of cervical cancer and its precursors. (2002) (64)
Hemorrhagic Complications Associated With Tension-Free Vaginal Tape Procedure (2004) (63)
Integrating bevacizumab, everolimus, and lapatinib into current neoadjuvant chemotherapy regimen for primary breast cancer. Safety results of the GeparQuinto trial. (2011) (63)
On the difference of micronucleus frequencies in peripheral blood lymphocytes between breast cancer patients and controls. (2006) (62)
Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients (2013) (62)
Dose-dense sequential chemotherapy with epirubicin(E), paclitaxel (T) and cyclophosphamide (C) (ETC) is superior to conventional dosed chemotherapy in high-risk breast cancer patients (≥ 4 +LN). First results of an AGO-trial. (2004) (61)
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 2 with Recommendations for the Therapy of Primary, Recurrent and Advanced Breast Cancer (2018) (61)
Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival—a retrospective multi-centre cohort study (2012) (61)
Long-term results after operative correction of vaginal aplasia. (1996) (60)
Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer. (1993) (60)
COMPliance and Arthralgia in Clinical Therapy: the COMPACT trial, assessing the incidence of arthralgia, and compliance within the first year of adjuvant anastrozole therapy. (2014) (60)
Pretreatment Staging of Cervical Cancer: Is Imaging Better Than Palpation? (2008) (58)
Immune responses to murine monoclonal antibody-B43.13 correlate with prolonged survival of women with recurrent ovarian cancer. (2003) (57)
Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass (2000) (57)
A comparison of international breast cancer guidelines - do the national guidelines differ in treatment recommendations? (2012) (55)
p53-based blood test for p53PIN3 and risk for sporadic ovarian cancer (1995) (55)
Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients (2013) (55)
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives. (2001) (55)
Quality of care in breast cancer centers: results of benchmarking by the German Cancer Society and German Society for Breast Diseases. (2015) (55)
Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial. (1994) (54)
Pre-operative staging of invasive breast cancer with MR mammography and/or PET: boon or bunk? (2002) (52)
Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients. (2012) (52)
Effects of low‐dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo‐controlled, double‐blind trial (2000) (50)
Certification of breast centres in Germany: proof of concept for a prototypical example of quality assurance in multidisciplinary cancer care (2009) (50)
Coping styles of pregnant women after prenatal ultrasound screening for fetal malformation. (2003) (50)
Regulation of endothelial proliferation by the renin-angiotensin system in human umbilical vein endothelial cells. (2008) (50)
Does Guideline-Adherent Therapy Improve the Outcome for Early-Onset Breast Cancer Patients? (2010) (48)
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer (2016) (47)
Interdisciplinary GoR level III Guidelines for the Diagnosis, Therapy and Follow-up Care of Breast Cancer: Short version - AWMF Registry No.: 032-045OL AWMF-Register-Nummer: 032-045OL - Kurzversion 3.0, Juli 2012. (2013) (45)
The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study. (2014) (45)
2008 update of the guideline: early detection of breast cancer in Germany (2009) (44)
Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells. (2003) (44)
Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study. (1998) (44)
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression. (2014) (44)
Tspan-1 is a tetraspanin preferentially expressed by mucinous and endometrioid subtypes of human ovarian carcinomas. (2009) (42)
First Revision of the German S3 Guideline ‘Diagnosis, Therapy, and Follow-Up of Breast Cancer’ (2008) (42)
Value of MR mammography in the detection and exclusion of recurrent breast carcinoma. (1997) (42)
CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans. (2007) (42)
Regulation of tight junction proteins occludin and claudin 5 in the primate ovary during the ovulatory cycle and after inhibition of vascular endothelial growth factor. (2007) (41)
Abstract S3-1: Lapatinib vs Trastuzumab in Combination with Neoadjuvant Anthracycline-Taxane-Based Chemotherapy: Primary Efficacy Endpoint Analysis of the GEPARQUINTO STUDY (GBG 44) (2010) (40)
Molecular mechanisms of ovarian hyperstimulation syndrome: paracrine reduction of endothelial claudin 5 by hCG in vitro is associated with increased endothelial permeability. (2009) (40)
Partial Breast Irradiation after Breast-Conserving Surgery (2005) (39)
Highly significant improvement in guideline adherence, relapse-free and overall survival in breast cancer patients when treated at certified breast cancer centres: An evaluation of 8323 patients. (2018) (38)
Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer--a multicentre, open, controlled, prospectively randomised trial. (2002) (38)
The power of DNA double‐strand break (DSB) repair testing to predict breast cancer susceptibility (2012) (37)
Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles (2012) (37)
Adenoviral Transduction Efficiency of Ovarian Cancer Cells Can Be Limited by Loss of Integrin β3 Subunit Expression and Increased by Reconstitution of Integrin αvβ3 (2001) (37)
MR mammography: influence of menstrual cycle on the dynamic contrast enhancement of fibrocystic disease (1999) (37)
The impact of epoetin-alpha on anemia, red blood cell (RBC) transfusions, and survival in breast cancer patients (pts) treated with dose-dense sequential chemotherapy: Mature results of an AGO phase III study (ETC trial) (2007) (36)
Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach. (2003) (36)
The role of preoperative ultrasound evaluation of inguinal lymph nodes in patients with vulvar malignancy. (2013) (36)
Mechanical agitation during the in vitro culture of human pre-implantation embryos drastically increases the pregnancy rate. (2010) (35)
Breast-conserving surgery and autogenous tissue reconstruction in patients with breast cancer: efficacy of MRI of the breast in the detection of recurrent disease (2003) (34)
Work–life balance of German gynecologists: a web-based survey on satisfaction with work and private life (2013) (34)
Cryobanking of human ovarian tissue for anti-cancer treatment: comparison of vitrification and conventional freezing. (2009) (34)
Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle (2012) (34)
Adding Epoetin Alfa to Intense Dose-Dense Adjuvant Chemotherapy for Breast Cancer: Randomized Clinical Trial (2013) (33)
The Screening, Diagnosis, Treatment, and Follow-Up of Breast Cancer. (2018) (33)
Impact of Guideline Conformity on Breast Cancer Therapy: Results of a 13-Year Retrospective Cohort Study (2010) (32)
Vitamin A and β-carotene supply of women with gemini or short birth intervals (2007) (32)
Basal expression of the multidrug resistance gene 1 (MDR-1) is associated with the TT genotype at the polymorphic site C3435T in mammary and ovarian carcinoma cell lines. (2002) (32)
The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients (2016) (30)
Helicobacter pylori infection and the occurrence and severity of gastrointestinal symptoms during pregnancy. (2003) (30)
Scoring variability of micronuclei in binucleated human lymphocytes in a case-control study. (2006) (30)
The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects. (2014) (30)
Evaluation of CA 125 as a prognostic and predictive factor in ovarian cancer (1988) (30)
Correlation of p 53 Mutations with Resistance to Platinum-based Chemotherapy and Shortened Survival in Ovarian Cancer 1 (2001) (29)
Cell junctional proteins in the human corpus luteum: changes during the normal cycle and after HCG treatment. (2006) (29)
p53 Autoantibodies in Patients with Primary Ovarian Cancer Are Associated with Higher Age, Advanced Stage and a Higher Proportion of p53-Positive Tumor Cells (1999) (29)
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV. (2012) (29)
Cooperative effect of adenoviral p53 gene therapy and standard chemotherapy in ovarian cancer cells independent of the endogenous p53 status (2004) (29)
Antitumor activity of new organometallic compounds in human ovarian cancer cell lines and comparison to platin derivatives. (1997) (28)
Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients. (2004) (28)
Subcellular localization of accumulated p53 in ovarian cancer cells. (1996) (28)
Prognostic Impact of Satellite-Lymphovascular Space Involvement in Early-Stage Cervical Cancer (2008) (27)
Ultrasound scanning for diagnosis of foetal abnormality and maternal anxieties in a longitudinal perspective (2002) (27)
Axilloscopy and endoscopic sentinel node detection in breast cancer patients (2000) (27)
Sentinel lymph node dissection only versus complete axillary lymph node dissection in early invasive breast cancer: a systematic review and meta-analysis. (2013) (26)
Vitamin A and beta-carotene supply of women with gemini or short birth intervals: a pilot study. (2007) (26)
Prediction of Nodal Involvement in Breast Cancer Based on Multiparametric Protein Analyses from Preoperative Core Needle Biopsies of the Primary Lesion (2008) (26)
Human papillomavirus integration is not associated with advanced epithelial ovarian cancer in German patients. (1995) (26)
Impact of the axillary nodal status on sentinel node mapping in breast cancer and its relevance for technical proceeding (2001) (26)
Predictors of the course of quality of life during therapy in women with primary breast cancer (2017) (26)
Neoadjuvant bevacizumab and anthracycline-taxane-based chemotherapry in 686 triple-negative primary breast cancers: Seconday endpoint analysis of the GeparQuinto study (GBG 44). (2011) (26)
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study (2016) (26)
Abstract P1-11-03: Pathological Complete Response after Neoadjuvant Chemotherapy + Trastuzumab Treatment Predicts Survival and Detects a Patient Subgroup at High Need for Improvement of Anti-HER2 Therapy. Three Year Median Follow-Up Data of the TECHNO Trial (2010) (26)
Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients. (2013) (26)
New Molecular Targets of Breast Cancer Therapy (2002) (26)
A sensitive test for the detection of specific DSB repair defects in primary cells from breast cancer specimens (2008) (26)
Haemorrhage and nerve damage as complications of TVT-O procedure: case report and literature review (2008) (25)
Endoscopic axillary surgery in breast cancer (2001) (25)
The Patients' View On Accredited Breast Cancer Centers: Strengths and Potential for Improvement. (2012) (25)
Differential expression of VE-cadherin and VEGFR2 in placental syncytiotrophoblast during preeclampsia - New perspectives to explain the pathophysiology. (2010) (24)
Pattern of metastatic spread and subcategories of breast cancer (2016) (24)
Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up. (2008) (23)
Long-term results of the tension-free vaginal tape procedure in an unselected group: a 7-year follow-up study. (2011) (23)
Human ovarian tissue cryopreservation: quality of follicles as a criteria of effectiveness. (2010) (23)
Sentinel node biopsy and axillary dissection in breast cancer: the evidence and its limits. (2014) (23)
Breast Cancer Patients' Fear of Treatment: Results from the Multicenter Longitudinal Study BRENDA II (2015) (23)
Abstract S4-6: Neoadjuvant Chemotherapy with or without Bevacizumab: Primary Efficacy Endpoint Analysis of the GEPARQUINTO Study (GBG 44) (2010) (23)
Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk for breast cancer (2002) (23)
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients (2014) (22)
Differential characteristics of two new tumorigenic cell lines of human breast carcinoma origin (1998) (22)
Comorbidity‐dependent adherence to guidelines and survival in breast cancer—Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients (2018) (22)
3H‐estradiol and 3H‐R5020 binding in cytosols of normal and neoplastic human ovarian tissue (1983) (22)
Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3. (2001) (22)
Optimizing the Quality of Breast Cancer Care at Certified German Breast Centers (2011) (22)
S2-4: GAIN Study: A Phase III Trial To Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients with Node-Positive Primary Breast Cancer – 1st Interim Efficacy Analysis. (2011) (22)
Spectrum of p53 mutations in biopsies from breast cancer patients selected for preoperative chemotherapy analysed by the functional yeast assay to predict therapeutic response. (2004) (21)
p53 autoantibodies can be indicative of the development of breast cancer relapse. (2003) (21)
Expression of CD44 standard and variant isoforms v5, v6 and v7 in human ovarian cancer cell lines. (1997) (21)
Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – A Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System (2010) (21)
Comparison of early onset breast cancer patients to older premenopausal breast cancer patients (2010) (20)
Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins. (2013) (20)
Corpus Uteri (2020) (19)
Predicting fatigue in older breast cancer patients receiving radiotherapy (2015) (19)
Ultrasound assessment of tension-free vaginal tape (TVT). (2010) (19)
Human ovarian tissue preservation: is vitrification acceptable method for assisted reproduction? (2008) (19)
Altered subcellular distribution of cadherin-5 in endothelial cells caused by the serum of pre-eclamptic patients. (2000) (18)
Trends in patient characteristics, treatment and survival in breast cancer in a non-selected retrospective clinical cohort study of 2,600 patients (2012) (18)
Discordant results obtained for different methods of HER-2/neu testing in breast cancer--a question of standardization, automation and timing. (2004) (18)
Regulated expression of the Renin-Angiotensin-System in human granulosa lutein cells: Angiotensin II increases VEGF expression but its synthesis is reduced by hCG (2010) (18)
Cryopreservation of spermatozoa Old routine and new perspectives (2011) (17)
Chicken ovalbumin upstream promoter transcription factor (COUP-TF): an orphan steroid receptor with a specific pattern of differential expression in human ovarian cancer cell lines. (1993) (17)
Phase I/II trial of multicycle high-dose chemotherapy with peripheral blood stem cell support for treatment of advanced ovarian cancer (2006) (17)
Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy (2011) (17)
Does chemotherapy improve survival in patients with nodal positive luminal A breast cancer? A retrospective Multicenter Study (2019) (16)
Key Informants' Perspectives on Accredited Breast Cancer Centres: Results of a Survey. (2012) (16)
Long time therapy with topotecan in patients with recurrence of ovarian carcinoma. (2001) (16)
Epoetin-alpha reduces red blood cell transfusions (RBC) in high-risk breast cancer patients with adjuvant dose-dense, sequential chemotherapy with epirubicin (E), paclitaxel (T) and cyclophosphamide (C) (ETC) (2005) (16)
Interdisciplinary GoR level III Guidelines for the Diagnosis , Therapy and Follow-up Care of Breast Cancer Short version – AWMF Registry No . : 032-045 OL (2013) (16)
Does patient education work in breast cancer? Final results from the global CARIATIDE study. (2015) (16)
Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy—results from the prospective multi-center study BRENDA II (2016) (16)
Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study (2016) (16)
Establishment of new ovarian and colon carcinoma cell lines: differentiation is only possible by cytokeratin analysis. (1994) (16)
Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines (1994) (15)
[Preoperative assessment of asymptomatic adnexal tumors by positron emission tomography and F 18 fluorodeoxyglucose]. (1999) (15)
Cytogenetic analysis of human zygotes displaying three pronuclei and one polar body after intracytoplasmic sperm injection. (2001) (15)
p53 mutant His175 identified in a newly established fallopian tube carcinoma cell line secreting interleukin 6 (1994) (15)
[Summary of the updated stage 3 guideline for early detection of breast cancer in Germany 2008]. (2008) (15)
EFFECTS OF PREVIOUS PREGNANCY LOSS ON LEVEL OF MATERNAL ANXIETY AFTER PRENATAL ULTRASOUND SCREENING FOR FETAL MALFORMATION (2005) (15)
Anthracycline and trastuzumab in breast cancer treatment. (2004) (15)
Pregnancy and delivery after tension-free vaginal tape (TVT) procedure: literature review and case report. (2010) (15)
Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast (1999) (15)
Immunohistochemical demonstration of carcinoembryonic antigen (CEA) in 120 mammary carcinomas and its correlation with tumor type, grading, staging plasma-CEA, and biochemical receptor status. (1985) (15)
Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL). (1993) (14)
The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects. (2014) (14)
A randomized phase III study evaluating pegylated liposomal doxorubicin (PLD) versus capecitabine (CAP) as first-line therapy for metastatic breast cancer (MBC): Results of the PELICAN study. (2010) (14)
[External fetal version from breech presentation to cephalic presentation: modifying factors, reliability and risks]. (1998) (14)
Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial (2009) (14)
Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines. (1993) (13)
Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients. (2015) (13)
Clinical utility of different tumor markers in breast cancer and gynecological malignancies. (1983) (13)
Career and Family - Are They Compatible?: Results of a Survey of Male and Female Gynaecologists in Germany. (2012) (13)
Effect of adjuvant radiotherapy in elderly patients with breast cancer (2020) (13)
Intron 9 retention in gene transcripts suggests involvement of CD44 in the tumorigenesis of ovarian cancer. (1997) (13)
Concentration of gynaecology and obstetrics in Germany: is comprehensive access at stake? (2014) (12)
Gain study: A phase III trial to compare ETC versus EC-TX and ibandronate versus observation in patients with node-positive primary breast cancer. (2016) (12)
Principles and Practice of Fertility Preservation: Cryopreservation of spermatozoa (2011) (12)
p53 mutation is associated with high S-phase fraction in primary fallopian tube adenocarcinoma. (1996) (12)
Results of the Zometa® Cost-Utility Model for the German Healthcare System Based on the Results of the ABCSG-12 Study (2010) (12)
Guidelines are advantageous, though not essential for improved survival among breast cancer patients (2015) (12)
p53 trans-dominantly suppresses tumor formation of human breast cancer cells mediated by retroviral bulk infection without marker gene selection: an expeditious in vitro protocol with implications towards gene therapy. (1995) (12)
Do T1a breast cancers profit from adjuvant systemic therapy? A multicenter retrospective cohort study of 325 T1a-patients (2016) (12)
Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011) (2011) (12)
Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? (2019) (11)
Pregnancy after the calcium ionophore correction of pronuclei position in oocytes after intracytoplasmic sperm injection. (2010) (11)
Exacerbation of a maternal hiatus hernia in early pregnancy presenting with symptoms of hyperemesis gravidarum: case report and review of the literature (2011) (11)
Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy (2006) (11)
Expression of urokinase-type plasminogen-activator (upa) and its receptor (upar) in human ovarian-cancer cells and in-vitro invasion capacity. (1994) (11)
Characterization of a human carcinosarcoma cell line of the ovary established after in vivo change of histologic differentiation. (2001) (11)
A preference-based index for the SF-12. (2006) (11)
Evaluation of SCC antigen as a tumor marker for cervical cancer: a cooperative study of the GTMG (1988) (11)
High estrogen receptor expression in early breast cancer: chemotherapy needed to improve RFS? (2011) (10)
Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer: a phase I trial. (1997) (10)
Stage IB endometrial cancer. Does lymphadenectomy replace adjuvant radiotherapy? (2007) (10)
Paclitaxel combined with carboplatin in the first-line treatment of advanced ovarian cancer. (1995) (10)
Geriatric assessment and biomarkers in patients with metastatic breast cancer receiving first-line mono-chemotherapy: Results from the randomized phase III PELICAN trial. (2017) (10)
Increased Radiosensitivity as an Indicator of Genes Conferring Breast Cancer Susceptibility (2007) (10)
Peanut lectin histochemistry of 120 mammary carcinomas and its relation to tumor type, grading, staging, and receptor status (2004) (10)
Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector. (2005) (9)
Is extracapsular nodal extension in sentinel nodes a predictor for nonsentinel metastasis and is there an impact on survival parameters?—A retrospective single center cohort study with 324 patients (2018) (9)
Genomic semi-automated cycle sequencing as a sensitive screening technique for p53 mutations in frozen tumor samples. (1998) (9)
Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients. (2000) (9)
New Aromatase Inhibitors (1998) (9)
Influence of Bladder Volume on Pelvic Organ Prolapse Quantification Results (2010) (9)
Retziusscopy: a minimal invasive technique for the treatment of retropubic hematomas after TVT procedure. (2011) (9)
Cervical ectopic pregnancy: surgical or medical treatment? (2007) (8)
Rad52 gene mutations in breast/ovarian cancer families and sporadic ovarian carcinoma patients. (2003) (8)
Focus on haematogenous dissemination of the malignant cystosarcoma phylloides: institutional experience (2011) (8)
Patient's Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer (2013) (8)
Factors influencing the development of visceral metastasis of breast cancer: A retrospective multi-center study. (2017) (8)
Prognostic value of HER2 on breast cancer survival. (2013) (8)
Stage IB Endometrial Cancer (2007) (8)
Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro (2000) (8)
Establishment and characterization of six new human endometrial adenocarcinoma cell lines. (1993) (8)
Methyl 17β-Carboxyester Derivatives of Natural and Synthetic Glucocorticoids: Correlation Between Receptor Binding and Inhibition of in vitro Phytohaemagglutinin-Induced Lymphocyte Blastogenesis (1983) (7)
Immunotherapy and cancer vaccines in the management of breast cancer. (2005) (7)
Droloxifene‐Induced Spikes of Tumor Markers Predict Benefit of Therapy (1991) (7)
Radiotherapy effects on early breast cancer survival in observational and randomized studies: a systematic analysis of advantages, disadvantages and differences between the two study types (2016) (7)
Medium-sized deletion in the BRCA1 gene: Limitations of Sanger sequencing and MLPA analyses (2012) (7)
Comparison of Transobturator Vaginal Tape and Retropubic Tension-Free Vaginal Tape: Clinical Outcome and Sonographic Results of a Case-Control Study (2009) (7)
Voiding Dysfunction after the Tension-Free Vaginal Tape Procedure (2011) (7)
Significant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes. (2007) (7)
Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients (2015) (7)
Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival (2017) (7)
Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer? (2015) (7)
Cervical hydatidiform mole pregnancy after missed abortion presenting with severe vaginal bleeding: case report and review of the literature. (2011) (7)
[Medicine and Economy: Measures for a Science Based, Patient-Centred and Resource Conscious Care. The Association of Scientific Medical Societies' (AWMF) Strategy Paper]. (2019) (6)
[Percutaneous ureteral occlusion. Methods, results, problems]. (1991) (6)
Value of ultrasound in preoperative local staging in early breast cancer. (2010) (6)
[General and specific laboratory parameters within the scope of tumor after-care in gynecologic malignancies and breast cancer]. (1989) (6)
A novel breast cancer cell line initially established from pleural effusion: evolution towards a more aggressive phenotype. (2007) (6)
Certification of Breast Centers (2004) (6)
[Diagnosis and treatment of malignant ovarian tumors 2005: recommendations of the Kommission Ovar of the AGO]. (2006) (6)
Are There Breast Cancer Patients with Node-Negative Small Tumours, Who Do Not Benefit from Adjuvant Systemic Therapy? (2017) (5)
[Endoscopic axillary lymph node excision--results of a pilot study]. (1999) (5)
17β-Carboxamide Steroids: Highly Effective Inhibitors of the Phytohaemagglutinin Mediated Blastogenesis of Normal Human Peripheral Lymphocytes (1984) (5)
Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9156 patients (2013) (5)
[Monoclonal antibodies in the diagnosis and follow-up of ovarian cancer. CA 125 as a tumor marker. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)]. (1986) (5)
Discordant Results Obtained for Different Methods of HER-2/Neu Testing in Breast Cancer – A Question of Standardization, Automation and Timing (2004) (5)
Identifying the impact of inflammatory breast cancer on survival: a retrospective multi-center cohort study (2015) (5)
p53 gain-of-function mutation in codon 175 is a rare event in human breast cancer. (1993) (5)
Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer) (2009) (5)
Suitable laparoscopic surgery in the treatment of ectopic interstitial pregnancy (2006) (5)
[Epidemiologic, infectiologic and immunologic results from gynecologic HIV consultation at the Mainz University Gynecologic Clinic]. (1989) (5)
Up front tandem high-dose chemotherapy (HD) compared to standard chemotherapy with doxorubicin and paclitaxel (AT) in metastatic breast cancer (MBC): Final results of a randomized trial. (2004) (5)
Survivors of primary breast cancer 5 years after surgery: follow-up care, long-term problems, and treatment regrets. Results of the prospective BRENDA II-study (2020) (5)
0157 GAIN study: A phase III trial to compare ETC vs. EC-TX and ibandronate vs. observation in patients with node-positive primary breast cancer (2009) (5)
Assessing the impact of CMF-like/Anthracycline-based/Anthracycline-Taxane-based/dose-dense chemotherapy in dependency of positive axillary lymph nodes/hormone receptor-status/grading/T-stage on survival - A retrospective multi-centre cohort study of 3677 patients receiving adjuvant chemotherapy. (2014) (5)
[The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)]. (1989) (5)
[Guideline for the Early Detection of Breast Cancer in Germany 2008. Recommendations from the short version]. (2008) (4)
Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression. (2017) (4)
[Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma]. (1990) (4)
Establishment and characterization of six new human endometrial adenocarcinoma cell lines (1993) (4)
[The value of MR-mammography at 1.5 tesla in the differential diagnosis of non-puerperal mastitis and inflammatory breast carcinoma]. (1996) (4)
[Problem of pretherapeutic staging of cervical carcinoma. Studies of the diagnostic value of computerized tomography and magnetic resonance tomography in comparison with gynecologic palpation findings and pathologic-anatomic diagnosis]. (1987) (4)
Which patient- and physician-related factors are associated with guideline adherent initiation of adjuvant endocrine therapy? Results of the prospective multi-centre cohort study BRENDA II (2017) (4)
Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study (2019) (4)
Gemcitabine and mitoxantrone in metastatic breast cancer: A phase-I-study (2005) (4)
Corrections to "Final analysis of the prospective WSG-AGO EC-Doc versus FEC phase III trial in intermediate-risk (pN1) early breast cancer: efficacy and predictive value of Ki67 expression". (2017) (4)
Safety and tolerability of adjuvant exemestane plus goserelin with or without tibolone in receptor-positive, node-negative primary breast cancer in premenopausal women: The final results of the randomized multicenter ADAGIO pilot study. (2004) (4)
P5-16-02: The Impact of Educational Materials on Compliance and Persistence with Adjuvant Aromatase Inhibitors: 2 Year Follow-Up and Final Results from the CARIATIDE Study. (2011) (4)
Assessment of Quality of Life in Postmenopausal Women with Early Breast Cancer Participating in the PACT Trial: The Impact of Additional Patient Information Material Packages and Patient Compliance. (2019) (4)
Complete resection of adnexal masses with endobag extraction: the risk of involuntary tumour rupture (2000) (3)
[Breast cancer: current recommendations for pathologists on the basis of the S3 guidelines]. (2013) (3)
[Immunodiagnosis and its relevance in neoplastic disease, immunotherapy in neoplastic disease]. (1990) (3)
64. Tamoxifen does not promote tumour progression in surgically treated endometrial cancer (1995) (3)
Surgery for elderly patients with ovarian cancer (2003) (3)
Drdloxifene: Efficacy and endocrine effects in treatment of metastatic breast cancer (1987) (3)
Molecular indicators of non-sentinel node status in breast cancer determined in preoperative biopsies by multiplexed sandwich immunoassays (2011) (3)
[Idiopathic habitual abortion: experiences with active immunotherapy]. (1995) (3)
[Women after surgically corrected vaginal aplasia: a follow-up of psychosexual rehabilitation]. (1993) (3)
T-cell receptor repertoire and function in umbilical cord blood lymphocytes from newborns of type 1 diabetic mothers (2004) (3)
Treatment of Advanced Ovarian Cancer in Germany: The Impact of Participation in Clinical Trials (2001) (3)
[Stage 3 recommendations--the early recognition of breast cancer in Germany. Abridged version for medical practitioners]. (2003) (3)
Reduction of the immunosuppressive action of chemotherapeutics in patients with mammary carcinoma by Azimexon. (1983) (3)
Sentinel node mapping in gynecologic malignancies (2000) (3)
Medroxyprogesterone acetate therapy in endometrial carcinoma mechanism of action pharmacokinetics and clinical investigations (1988) (3)
First results from the Patient's Anastrozole Compliance to Therapy (PACT) program evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer (EBC). (2010) (3)
P5-17-05: 24 Months Follow-Up Results from PACT (Patient's Anastrozole Compliance to Therapy Programme), a Non-Interventional Study Evaluating the Influence of a Standardized Information Service on Compliance in Postmenopausal Women with Early Breast Cancer. (2011) (3)
Ovarian Metastasis of a Lymphoma Presenting as Primary Ovarian Cancer (2009) (3)
BRENDA: Breast Cancer Care under evidence-based Guidelines. Ein Projekt aus der Versorgungsforschung (2010) (3)
Supportive therapy with epoetin-alpha in breast cancer patients (pts) receiving dose-dense sequential chemotherapy with epirubicin, paclitaxel and cyclophosphamide (ETC) (2001) (3)
[Sentinel node biopsy in breast cancer. German Society for Senology defines quality standards]. (2004) (3)
Results of tension-free vaginal tape procedure in patients with or without colporrhaphy (2007) (3)
Triple-negative breast cancer: The effect of guideline-adherent adjuvant treatment on the cumulative survival-A retrospective multicenter cohort study of 3,658 patients. (2011) (3)
[Possibilities and limits of the study of tumor markers in the after-care of patients with ovarian cancer]. (1986) (3)
Impact of guideline conform local-regional treatment on survival of breast cancer patients: An analyses of the BRENDA-study group (2008) (3)
[Influence of x-rays on the B- and T-cells in the spleen of mice and their reaction on mitogenetic substances (author's transl)]. (1979) (3)
Topotecan (Hycamtin) in the Therapy of Recurrent Ovarian Carcinoma (1998) (2)
Fertility Cryopreservation: Concept of human ovarian tissue cryobanking (2010) (2)
Modulation of soluble CD44 concentrations by hormone and anti-hormone treatment in gynecological tumor cell lines. (2001) (2)
DGGG Guidelines Programme: Status Quo - Quo Vadis! (2014) (2)
Breast Cancer in Young Women (2009) (2)
Sentinel node biopsy in breast cancer - technical performance is more important than patient selection to avoid false-negative findings (2001) (2)
[Intraobserver and interobserver reliability of introital ultrasound after tension-free vaginal tape (TVT) procedure]. (2011) (2)
[Fundamentals and clinical significance of steroid hormone receptors, 17 beta-hydroxysteroid-dehydrogenase and serum tumor markers in endometrial carcinoma]. (1983) (2)
Risk awareness and transparency. (2013) (2)
24-month follow-up from the Patient's Anastrozole Compliance to Therapy (PACT) program evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer. (2011) (2)
11th International Conference St. Gallen: Primary Therapy of Early Breast Cancer (2009) (2)
["Deciding wisely together" - an initiative of the Association of the Scientific Medical Societies in Germany: Mission, methodology and application]. (2017) (2)
Protein multiplex sandwich immunoassay: A reliable and objective method for complete molecular characterization of breast cancer from core needle biopsies. (2006) (2)
POSTER VIEWING SESSION - EMBRYOLOGY (2011) (2)
Medroxyprogesterone acetate: steady-state pharmacokinetics bioequivalence of two oral formulations (2004) (2)
[Tumor markers and their significance in gynecologic oncology]. (1980) (2)
[The gynecologist as 'family doctor for women' - a model of the future?]. (2004) (2)
Patient's Anastrozole Compliance to Therapy Programme (PACT) influence of the addition of a standardized information and reminder service on compliance in comparison to standard clinical care alone in women with early breast cancer (2008) (2)
Reply to Schrodi et al. 2015 (2015) (2)
Oxaliplatin (OXA) in patients (pts) with advanced ovarian cancer (AOC) after failure of topotecan (TOPO) based chemotherapy (2002) (2)
[Diabetes screening in pregnant patients with different risk factors. Benefits, therapeutic success, consequences]. (1995) (2)
Disease-Management Mammakarzinom (2002) (2)
Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years. (2001) (2)
Intense dose-dense (idd) sequential chemotherapy with epirubicin (E), paclitaxel (T), and cyclophosphamide (C) (ETC) compared with conventionally scheduled chemotherapy in high-risk breast cancer patients (> 3+LN): Eight-year follow-up analysis. (2011) (2)
[Coping strategies of high-risk pregnancies with threat of premature birthø]. (1999) (2)
High-Dose Chemotherapy with Autologous Haematopoietic Stem Cell Support in Advanced Ovarian Cancer (1997) (2)
Significant Changes in Circulating Plasma Levels of IGF1 and IGFBP3 after Conventional or Dose-Intensified Adjuvant Treatment of Breast Cancer Patients with one to three Positive Lymph Nodes (2007) (2)
Clinical efficacy of leuprorelin acetate monthly depot in premenopausal patients with metastatic breast cancer. (1997) (2)
Interim safety analysis of the randomized phase III PELICAN trial evaluating pegylated liposomal doxorubicin (PLD) versus capecitabine as first-line therapy for metastatic breast cancer. (2016) (2)
[Integrating the e-learning programme EGONE into the block of training in obstetrics and gynaecology]. (2012) (2)
[From alcohol abstinence to total surgery. Preventive strategies in breast carcinoma]. (2003) (1)
[Results of surgical treatment of vulvar cancer]. (1990) (1)
[The influence of pregnancy specific serum factors on the mitogen induced culture of lymphocytes (author's transl)]. (1979) (1)
Abstract P6-09-08: COMPliance and Arthralgia in Clinical Therapy: The COMPACT trial, assessing the incidence of arthralgia, therapy costs and compliance within the first year of adjuvant anastrozole therapy (2012) (1)
First data from the the Patient's Anastrozole Compliance to Therapy Programme evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer. (2016) (1)
[Therapy of anthracycline-resistant metastatic breast carcinoma]. (1998) (1)
[Computer support of workflow in the hospital: concepts, technology and application]. (2000) (1)
[Predicting response to therapy in breast cancer]. (2008) (1)
Rechallenging taxanes in recurrent breast cancer in patients treated with (neo-) adjuvant taxane-based therapy. (2011) (1)
17 beta-carboxamide steroids: highly effective inhibitors of the phytohaemagglutinin mediated blastogenesis of normal human peripheral lymphocytes. (1984) (1)
[Results of testing tumor resistance (in vitro--in vivo) in breast cancer]. (1987) (1)
[Electrophoresis mobility inhibition test (emt) in immunological early diagnosis of gynaecological malignomas (author's transl)]. (1979) (1)
P343 CARIATIDE trial: the impact of educational materials (EM) on patients' compliance with adjuvant aromatase inhibitor (AI) therapy and quality of life (QoL) (2011) (1)
ANGIOTENSIN II DEPENDENT GENE REGULATION IN HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS INVOLVES VEGF-SIGNALING AND ANGIOGENESIS (2007) (1)
An International Proficiency Study with the Tumor Marker CA 125 (1990) (1)
Fertility Cryopreservation: Cryopreservation of human oocytes and embryos either by direct plunging into liquid nitrogen or by using an aseptic approach (2010) (1)
1 High dose megestrol acetate in metastatic breast cancer: Mechanisms of action (1987) (1)
[Examinations carried out in order to determine the effects of a radiotherapy on the immunity situation of tumor patients (author's transl)]. (1979) (1)
Prognostic impact of satellite-lymphovascular space involvement in early stage cervical cancer – LVSI in cervical cancer (2008) (1)
[Abnormal glucose tolerance and insulin resistance after diabetes in pregnancy]. (1995) (1)
[The diagnosis of post-operative lymphatic cysts in the pelvis (author's transl)]. (1980) (1)
Abstract P3-09-06: Frequency of and reasons for deviation from therapy decisions in patients with primary breast cancer initially intended to receive chemotherapy – Results from the German prospective multi-center study BRENDA II (2015) (1)
Internet expert system on breast cancer — Two years experience with a German web site (www.mammakarzinom.de) (1999) (1)
[An unusual case: vaginal foreign body (forceps) as an incidental finding during primary operation for breast cancer]. (1995) (1)
BRENDA-Score, a Highly Significant, Internally and Externally Validated Prognostic Marker for Metastatic Recurrence: Analysis of 10,449 Primary Breast Cancer Patients (2021) (1)
Contralateral breast cancer risk in patients with familial breast cancer who tested negative for BRCA1 and BRCA2. (2011) (1)
Prevalence Rates of Pathogenic Mutations in theBRCA1andBRCA2Genes in Families with Different Disease Histories: Results from the German Consortium for Hereditary Breast and Ovarian Cancer. (2009) (1)
Tumor-infiltrating lymphocytes in breast cancer tissue comprise granzyme B-expressing B cells with cytotoxic potential (127.23) (2012) (1)
4265 Pegfilgrastim on day 2 vs. day 4 within the prospective, multi- centered GAIN study: A phase III trial to compare ETC vs. EC-TX and ibandronate vs. observation in patients with node-positive primary breast cancer (GBG 33) (2009) (1)
Ovarialkarzinom: State of the art, Trends, Kontroversen (Teil 1) (2006) (1)
Antiproliferative activity of tamoxifen on MCF-7 breast cancer cells is modulated by weak electromagnetic field exposure (2004) (1)
[New developments in the area of markers in diagnosis and monitoring of ovarian cancer]. (1985) (1)
Basic and clinical relevance of hormonal influence in breast cancer. (1990) (1)
Tumor-infiltrating lymphocytes in breast cancer tissue comprise granzyme B-expressing B cells with cytotoxic potential (2012) (1)
[Good Prognosis! Breast Cancer Update 2016]. (2016) (1)
Effect of very small tumor size on recurrence-free survival and breast cancer-specific mortality stratified by guideline adherence: An analysis of the BRENDA Study Group. (2013) (1)
[Breast cancer: importance of environmental factors in its formation]. (1998) (1)
[Effect of different follicle puncture methods on hormone homeostasis in the woman. Studies within the scope of an in vitro fertilization-embryo transfer program]. (1994) (0)
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]. (2016) (0)
66 The cariatide study: evaluation of the impact of educational material on the compliance and persistence rates to adjuvant aromatase inhibitor medication in postmenopausal breast cancer patients: baseline data (2009) (0)
Response to: Importance of work–life balance among German medical students who wish to become gynecologists (2015) (0)
Prevalence of serum p53 autoantibodies in ductal carcinoma in situ of the breast at the time of diagnosis (1998) (0)
Onkologie. BRENDA („Quality of breast cancer care under evidence based guidelines“) - Ein Studiennetzwerk der Versorgungsforschung (2010) (0)
CARIATIDE trial: the impact of educational materials (EM) on patients' compliance with adjuvant aromatase inhibitor (AI) therapy and quality of life (QoL) (2011) (0)
[Reactive immunologic changes during intraarterial methotrexate therapy in patients with carcinoma of the oropharynx (author's transl)]. (1979) (0)
71 BABIES BORN AFTER ICSI WITH MOTILE SPERMATOZOA VITRIFIED WITHOUT CRYOPROTECTANTS (2010) (0)
Abstract P5-14-03: The impact of adjuvant radiotherapy on survival in primary breast caner: What is the role of guideline adherence in radiotherapy – A retrospective multi-center cohort study of 8935 (2013) (0)
[Adjuvant chemotherapy in breast neoplasms. Clinical and immunologic results]. (1980) (0)
107. Partly purification of the human spleen tumor glucocorticoid receptor (GlucR) (1982) (0)
[Modern therapy of breast carcinoma: more time for living]. (2003) (0)
Effect of droloxifene treatment in metastatic breast cancer on tumor markers (1987) (0)
The prognostic B2-Score for metastatic breast cancer: An external evaluation of 852 patients. (2014) (0)
[Drug therapy in pregnancy--a practical guide]. (2004) (0)
Influence of Treatment Conforming to Guidelines on Recurrence Free Survival (RFS) and Overall Survival (OS) in Triple Negative Breast Cancer. (2009) (0)
Accuracy of endoscopie axillary lymph node dissection in breast cancer patients (1998) (0)
2 Overview of clinical results with high dose medroxyprogesterone acetate in comparison with megestrol acetate in advanced breast cancer (1987) (0)
4.2 Operative Therapiekonzepte – Operationsnavigator (2009) (0)
Contents, Vol. 31, 1991 (1991) (0)
Is guideline-adherent adjuvant treatment an equivalent option for elderly patients who cannot participate in adjuvant clinical breast cancer trials? A retrospective multicenter cohort study of 4,142 patients. (2014) (0)
Prognostic value of CA27.29 trend during adjuvant chemotherapy and until 2 years thereafter in patients with primary breast cancer. (2011) (0)
Subject Index Vol. 57, 1999 (1999) (0)
Does the number of removed axillary lymphnodes in high risk breast cancer patients influence the survival? (2019) (0)
Interleukin-21-induced granzyme B-expressing B lymphocytes regulate T cells and infiltrate human solid tumors (2012) (0)
Peritoneal metastases in breast cancer patients: Differences in survival depending on histological subtype. (2016) (0)
Early onset breast cancer; Ergebnisse der BRENDA Studie (2009) (0)
Non-compliance in adjuvant endocrinal treatment of breast cancer (2007) (0)
Ovarian dysfunction: Classification, diagnosis and therapy (2007) (0)
Adjuvant chemotherapy for breast cancer. (1986) (0)
Band 23, Heft 2, April 2000 (2000) (0)
Contents, Vol. 34, 1994 (1994) (0)
HCG Regulates Luteal Vascular Permeability via VEGF by Down Regulation of a Cascade of Adhesion Proteins. (2011) (0)
Cooperation between all partners involved as the key to success (1999) (0)
Retroperitoneal vascular leakage in ovarian cancer is associated with increased VEGF. (2008) (0)
Systematic therapy for carcinoma of the cervix (1999) (0)
[Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer]. (1993) (0)
5 Megestrol acetate treatment of metastatic breast cancer patients: Pharmacokinetics of megestrol acetate and influence on serum levels of androstendione, dheas, hydrocortisone, acth, prolactin, estrone, estradiol, LH and FSH (1987) (0)
Participation in adjuvant clinical breast cancer trials: Is there a difference in survival compared to guideline adherent adjuvant treatment? A retrospective multicenter cohort study of 5,326 patients. (2012) (0)
[Documentation Time and Effort and Associated Resources for Patients with Primary Breast Cancer from Diagnosis to End of Follow-Up - Results of a Multicentre Validation]. (2016) (0)
Abstract P6-11-06: Correlation Comprehensive Geriatric Assessment (CGA) and Inflammation and Nutrition Parameters with Outcome Measures in the Phase III PELICAN Trial for Metastatic Breast Cancer (MBC) (2010) (0)
Effect of anthracyclin-based neoadjuvant chemotherapy on disseminated tumor cells in breast cancer patients: an immunocytologic and molecular approach (2001) (0)
Autorenregister Vol. 34, 1994 (1994) (0)
C-erbB-2 overexpression in primary breast cancer: relationship to clinical and histopathological parameters of patients with breast cancer (2001) (0)
R-159. Unfertilized oocytes after intracytoplasmic sperm injection: chromosomal abnormalities and state of the sperm nucleus (1999) (0)
5035 The patient's anastrozole compliance to therapy programme (PACT): evaluating the influence of a standardized information service on compliance in postmenopausal women with early breast cancer (2009) (0)
To which extent do breast cancer survivors feel well informed about disease and treatment 5 years after diagnosis? (2020) (0)
[Significance of pathological alpha-1-fetoprotein levels in the framework of prenatal diagnosis]. (1992) (0)
[Artificial intelligence (AI)]. (2021) (0)
[Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study]. (2011) (0)
[Doubtful mammographic findings: the value of negative MR mammography for tumor exclusion]. (1997) (0)
[New knowledge on immunology in gynecologic cancer]. (1987) (0)
Contents Vol. 92, 2017 (2017) (0)
Second Trimester Ultrasound Screening (2008) (0)
Geriatric screening of older breast cancer patients – a pilot project (2011) (0)
Detection of P-Glycoprotein 170 in Ovarian Carcinoma Cell Lines and Enhancement of Its Expression after Induction of in vitro Resistance (1993) (0)
POSTOPERATIVELY ELEVATED SERUM LEVEL OF HER2 EXTRACELLULAR DOMAIN IS RELATED WITH LYMPH NODE METASTASIS OF PRIMARY BREAST CANCER IN A POPULATION BASED STUDY (2003) (0)
Congress Reports · Kongressberichte (2011) (0)
Title Page, Vol. 18, Suppl. 3, 1995 (1995) (0)
AB1394 Compliance and arthralgias in clinical therapy (compact): Assessment of the incidence of arthralgia, therapy costs and compliance within the first year of anastrozole therapy (2013) (0)
Advanced stages of invasive carcinoma of the cervix Operative therapy: Operative Therapie (1999) (0)
Adjuvante und definitive Radio-Chemo-Therapie des Vulvakarzinoms (2009) (0)
Inhibition of angiogenic activity in endothelial cells by blockade of the Renin-Angiotensin-system (2008) (0)
[Do preparation techniques induce ultrastructural sperm damage? An electron microscopic study]. (1994) (0)
Adjuvant hormonotherapy (Tamoxifen versus medro-xyprogesterone acetate versus control) in women with endometrial cancer, figo stage I and II (1986) (0)
Clinical Results of Topotecan (Hycamtin): Associated Symposium at the 23rd National Cancer Congress of the German Cancer Society, Berlin, June 1998 (1999) (0)
Tspan-1 is a molecular characteristic of ovarian carcinomas (2006) (0)
R-077. Embryo transfer after in-vitro fertilization: is one embryo really enough? O-535 (1999) (0)
Microenvironment and Immunology Interleukin 21 – Induced Granzyme B – Expressing B Cells In fi ltrate Tumors and Regulate T Cells (2013) (0)
Topotecan: A ''compassionate use'' study in patients with advanced epithelial ovarian cancer refractory to other therapies (1997) (0)
[Monitoring the immune status of breast cancer patients under adjuvant chemotherapy and polychemotherapy]. (1979) (0)
[Intra-arterial preoperative chemotherapy of advanced cervix cancer]. (1991) (0)
Cost-effectiveness of anastrozole versus tamoxifen as adjuvant therapy in early breast cancer (EBC) – a German health economic analysis. (2009) (0)
Abstract P5-11-12: Quality of Life in the PACT-Programme (Patient's Anastrozole Compliance to Therapy Programme): Influence of a Standardized Information Service on Patient Satisfaction and Health Related Quality of Life in Postmenopausal Women with Early Breast Cancer (EBC) (2010) (0)
[Initial pregnancies after intravaginal transport and partial zona dissection of human ova]. (1994) (0)
[Cytogenetic abnormalities in sperm: a risk factor for application of medical reproduction techniques?]. (1995) (0)
[Electrophoresis mobility test for early immunologic diagnosis of malignant gynecologic tumors]. (1979) (0)
[Cytogenetics of unfertilized or uncleaved oocytes within the scope of in vitro fertilization: correlation with maternal age]. (1993) (0)
[Surgical management of ovarian ectopic pregnancy]. (2006) (0)
Risk assessment, early diagnosis and gene replacement therapy: p53 to attack current problems in the management of ovarian cancer (1998) (0)
Prediction of axillary lymphatic node status in primary breast cancer — Comparison between positron emission tomography (PET) and sentinel-node biopsy (1998) (0)
[Effect of peroral BCG therapy on immune status of breast cancer patients during chemotherapy]. (1979) (0)
Interleukin-21-Induced Granzyme B-Expressing B Lymphocytes Infiltrate Tumors and Regulate T Cells (2012) (0)
[Cervical carcinoma stage Ia/2]. (1994) (0)
[Amniocentesis in prenatal diagnosis for psychological reasons]. (1992) (0)
[The influence of pregnancy on the immunologic reactivity of the mother. Investigations into the reactivity of the peripheral lymphocytes to mitogens and on the percentage rate of B-cells in the maternal blood during pregnancy (author's transl)]. (1977) (0)
[Alpha fetoprotein in the diagnosis of fetal abnormalities]. (1979) (0)
5.2 Operative Therapiekonzepte – Operationsnavigator (2009) (0)
Frequent RASSF 1 A Gene Promoter Hypermethylation in Breast Cancer (2008) (0)
[Inhibition of lymphocyte reactivity by pregnancy-associated serum factors]. (1979) (0)
Guideline-conform systemic treatment improves survival of breast cancer patients. (2009) (0)
Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study (2022) (0)
[The effect of oral BCG treatment on the immune system of cancer patients (proceedings)]. (1977) (0)
15th Annual Meetings: Association for Oncology of the Upper Rhine (AOR) (1998) (0)
Pregnancy after clomiphen stimulation in advanced kidney disease (2001) (0)
Human Papillomavirus and Cervical Cancer (2007) (0)
Effect of primary anthracycline-based chemotherapy on disseminated tumor cells in locally advanced breast cancer. (2004) (0)
Ovarialkarzinom: State of the art, Trends, Kontroversen (Teil 2) (2006) (0)
Subject Index Vol. 32, 2009 (2009) (0)
Clinical Outcome of Topotecan: New Strategies Play an Important Role in the Treatment of Lung Cancer, Other Solid Tumors, and Hemoblastosis (1998) (0)
Correlation between Mitotic Delay and Micronucleus Assay in Breast cancer patients (2008) (0)
Patient's Anastrozole Compliance to Therapy Programme (PACT): Influence of the addition of a standardized information and reminder service on compliance in comparison to standard clinical care alone in women with early-stage breast cancer (2008) (0)
[Adjuvant chemotherapy in breast and ovarian carcinoma]. (1991) (0)
Significant changes in circulating plasma levels of IGF1 and IGFBP3 after conventional or dose-intensified adjuvant treatment of breast cancer patients with one to three positive lymph nodes. (2007) (0)
Clinical significance of the tumor marker squamous-cell carcinoma antigen in diagnosis and follow-up of cervical cancer (1990) (0)
[Krukenberg tumor: a clinical case report]. (1997) (0)
Genotype and haplotype analysis reveal an association of p53 polymorphisms with breast cancer (1998) (0)
Molecular classification of breast cancer and prediction of therapeutic response (2007) (0)
Contents Vol. 32, 2009 (2009) (0)
6th International Meeting on Progress in Radio-Oncology, ICRO/ÖGRO 6 (1998) (0)
Table of Contents, Vol. 18, Suppl. 3, 1995 (1995) (0)
High dose medroxyprogesterone acetate therapy in mammary carcinoma patients: Clinical and biochemical results (1986) (0)
Association of lymphatic vessel invasion and progression of cervical cancer with focused expression of CD9. (2004) (0)
Gynecological Cancers: A Challenge of Individualized Therapy in the Adjuvant and Palliative Setting (2003) (0)
[Plasma lipoprotein fractions in high-dose medroxyprogesterone acetate therapy in metastatic breast cancer]. (1991) (0)
Early D etection a nd A ccurate D escription o f E xtent o f Metastatic B one D isease i n B reast C ancer W ith F luoride Ion a nd P ositron E mission T omography (1999) (0)
German-Swiss Expert Forum San Antonio, 12 December 2008 (2009) (0)
Comparing the outcome between multifocal, multicentric, and bilateral breast cancer and the impact of guideline-adherent adjuvant treatment: A retrospective multicenter cohort study of 5,308 patients. (2012) (0)
IS CLAUDIN 5 INVOLVED IN REGULATION OF ANGIOGENESIS AND PERMEABILITY IN THE PRIMATE OVARY (2007) (0)
The impact of breast cancer biological subtyping on tumor size assessment by ultrasound and mammography - a retrospective multicenter cohort study of 6543 primary breast cancer patients (2016) (0)
[Stem cell supported high dose chemotherapy (HDCT) in primary treatment of advanced ovarian carcinoma]. (1999) (0)
Regulation of VEGF, HIF-2α, and TIMP-1 in human breast cancer cells by angiotensin II and its receptor antagonist candesartan (2007) (0)
Targeting the Renin-Angiotensin System for New Anti-angiogenic Therapeutic Strategies in Gynecology (2009) (0)
Surgical Treatment of Breast Cancer – Current Status and New Concepts (2000) (0)
Mechanisms of Micronuclei induction due to reduced repair capacity (2007) (0)
Neonatal Outcome of Very Low Birth Weight Infants with Premature Rupture of Membranes (PROM) before 25 weeks and median latency of 46 days (1999) (0)
[Potential tumor preventive effects of hormone preparations]. (1993) (0)
6.2 Operative Therapiekonzepte – Operationsnavigator (2009) (0)
Compliance and arthralgias in clinical therapy (COMPACT): Assessment of the incidence of arthralgia, therapy costs, and compliance in the first year of adjuvant anastrozole. (2012) (0)
Endocrine-metabolic effects of a high-dosage gestagen therapy in advanced breast cancer (1987) (0)
High dose medroxyprogesterone acetate therapy in advanced breast cancer: Pharmacokinetics and clinical results (1987) (0)
What Is the Status Quo of Breast Cancer Research at Germany's Universities? (2010) (0)
First Results from the “Patient's Anastrozole Compliance to Therapy Programme” (PACT) Evaluating the Impact of a Standardized Information Service on Compliance in Postmenopausal Women with Early Breast Cancer (EBC) Receiving Adjuvant Endocrine Therapy. (2009) (0)
The influence of various dosages of medroxyprogesterone acetate on SHBG in advanced breast cancer (1987) (0)
6 The influence of various dosages of megestrol acetate on SHBG, CBG and lipoprotein patterns (1987) (0)
[Immunological competence of newborns. Investigations into distribution of different lymphocyte populations and their-function in umbilical blood]. (1982) (0)
[Possibilities and limitations of hysteroscopy in the diagnosis of uterine neoplasms]. (1977) (0)
[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression]. (1995) (0)
Oxaliplatin in patients with advanced ovarian cancer after failure of Topotecan and/or liposomal doxorubicin based chemotherapy (2003) (0)
Band 23, Supplement 2, April 2000 (2000) (0)
Inhalt, Vol. 17, Supplement 1, 1994 (1994) (0)
[Clinical follow-up studies on the prognostic significance of immunohistochemical estrogen receptor determination of breast cancer]. (1990) (0)
Which patient- and physician-related factors influence guideline adherence in adjuvant endocrine therapy?: Results of the prospective multi-center cohort study BRENDA II. (2015) (0)
Contents, Vol. 33, Supplement 1, 1993 (1993) (0)
Infections under chemotherapy (1999) (0)
[Results of pathohistological and differential diagnostic studies in 4000 breast biopsies]. (1971) (0)
Pharmacokinetics, safety and efficacy of pegfilgrastim in dose-dense, sequential adjuvant chemotherapy for patients with breast cancer (BC) (2008) (0)
Abstract P1-10-03: CARIATIDE: The Impact of Educational Materials and Demographic Characteristics on Compliance with Adjuvant Aromatase Inhibitor Treatment (2010) (0)
7.2 Operative Therapiekonzepte – Operationsnavigator (2009) (0)
BRCA1 and BRCA2 mutations in Germany - indications for testing in hereditary breast and ovarian cancer families. (2004) (0)
[Magnetic resonance tomography in the diagnosis of cervix cancer. Computed tomographic and histological correlations]. (1988) (0)
Impact of study participation on survival of early-stage breast cancer patients: Results from the BRENDA study, a multicenter clinical cohort on quality of breast cancer care. (2016) (0)
[Changes in tubal sterilization through the years 1955-1975 (proceedings)]. (1977) (0)
FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients (2014) (0)
Surgery for elderly patients with ovarian cancer. (2003) (0)
PD06-07: COMPliance and Arthralgias in Clinical Therapy (COMPACT): Assessment of the Incidence and Severity of Arthralgia, Treatment Costs and Compliance within the First Year of Adjuvant Anastrozole Therapy. (2011) (0)
Assessing the impact of CMF/FEC/FEC-DOC/ETC (dose-dense) adjuvant chemotherapy in dependency of positive axillary lymph nodes on survival: A retrospective multicenter cohort study of 4,526 breast cancer patients receiving adjuvant chemotherapy. (2013) (0)
Relevance of biochemical parameters in the prenatal diagnosis of dysraphic malformations (1986) (0)
There Is a Significant Association between 100% Treatment Adherence and Higher Recurrence-Free and Overall Survival in Early-Onset Patients with Breast Cancer – Conclusions from an Empty Subset of Patients Do Not Change This Statement (2011) (0)
[Smoking--a possible cause for failure in IVF/ET treatment?]. (1995) (0)
1.2 Instrumentarium (2009) (0)
Evaluation of hormone receptor and benefit from adjuvant chemotherapy in breast cancer patients with intermediate- and high-risk disease. (2010) (0)
Evaluation of CA 27.29 as Prognostic Marker in Primary Breast Cancer Patients – Results of the German SUCCESS Trial. (2009) (0)
Subject Index Vol. 23, 2000 (2000) (0)
Importance of the Renin-Angiotensin-System in human granulosa lutein cells – RAS in granulosa cells (2008) (0)
[Expression of the cell surface receptor for thrombin, thrombomodulin, in human ovarian cancer cells]. (1993) (0)
Patient's Anastrozole Compliance to Therapy Programme (PACT) – Influence of the addition of a standardized information and reminder service on compliance in comparison to standard clinical care alone in women with early breast cancer (2007) (0)
THE IMPACT OF EDUCATIONAL MATERIAL (EM) ON COMPLIANCE AND PERSISTENCE RATES WITH ADJUVANT AROMATASE INHIBITOR (AI) TREATMENT: FIRST YEAR DATA, PRESENTED ON BEHALF OF THE CARIATIDE STUDY INVESTIGATORS (2010) (0)
Increased Micronuclei frequencies in peripheral blood lymphocytes: a marker for cancer risk? (2006) (0)
Guideline Compliant Irradiation Following Breast Conserving Surgery or Mastectomy Improves Recurrence Free Survival. (2009) (0)
Abstract P5-11-05: Influence of Demographic and Histopathological Characteristics on Compliance and Persistence in 4.923 Postmenopausal Women with Early Breast Cancer (EBC) - Results of the Patient's Anastrozole Compliance to Therapy Programme (PACT) (2010) (0)
Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer (2016) (0)
[Recent therapeutic options and expectations to the pathologist]. (2005) (0)
Interleukin-21-induced granzyme B-expressing B lymphocytes regulate T cells and infiltrate tumors (P1088) (2013) (0)
OCCLUDIN EXPRESSION IN THE PRIMATE OVARY DURING NORMAL CYCLE AND AFTER INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (2007) (0)
128 OPTIMUM FOR CRYOPRESERVATION OF HUMAN OVARIAN TISSUE: GENE EXPRESSION AS A DETECTOR OF EFFECTIVENESS (2010) (0)

This paper list is powered by the following services:

Other Resources About Rolf Kreienberg

en.wikipedia.org

What Schools Are Affiliated With Rolf Kreienberg?

Rolf Kreienberg is affiliated with the following schools:

Rolf Kreienberg's Academic­Influence.com Rankings